Alkeus Pharmaceuticals : Developing treatments for blindness, in particular dry-AMD and Stargardt disease.
Alkeus Pharma is a clinical stage biopharmaceutical company

» dry-AMD

The most common form of unpreventable blindness, dry-AMD affects the vision of millions of Americans. Click here to learn more about dry-AMD and our future trials.

» Stargardt Disease

A rare genetic condition, Stargardt disease is a major, currently untreatable cause of juvenile blindness. We are now seeking participants for a Phase 2 clinical trial in the USA. Click here to learn more.

» Our Science

Our drug candidates result from innovative research by ophthalmic scientists. Click here to learn more about vision and our animal data for ALK-001 our lead drug candidate in clinical trials.

» About Us

Our team is experienced and dedicated to developing treatments for blindness. We collaborate heavily with leading physicians worldwide. Click here to learn more about Alkeus Pharmaceuticals.